Almost thirty years ago, scientists proved that the inactivation of PAX2 by different approaches, such as antisense oligonucleotides, small interfering RNA (siRNA) or small hairpin RNA (shRNA), results in the growth inhibition of human renal cell carcinoma in vitro. Here, PAX2 is linked to hereditary clear cell renal cell carcinoma.